Literature review of distal deep vein thrombosis.
Anticoagulants
/ adverse effects
Clinical Decision Rules
Compression Bandages
Conservative Treatment
Drug Administration Schedule
Exercise Therapy
Fibrin Fibrinogen Degradation Products
/ analysis
Humans
Incidence
Practice Guidelines as Topic
Recurrence
Risk Factors
Ultrasonography
Vena Cava Filters
Venous Thrombosis
/ complications
Diagnosis
Distal deep vein thrombosis
Management
Outcome
Journal
Journal of vascular surgery. Venous and lymphatic disorders
ISSN: 2213-3348
Titre abrégé: J Vasc Surg Venous Lymphat Disord
Pays: United States
ID NLM: 101607771
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
24
09
2020
accepted:
28
01
2021
pubmed:
13
2
2021
medline:
20
1
2022
entrez:
12
2
2021
Statut:
ppublish
Résumé
Although distal deep vein thrombosis (DDVT) has been more frequently diagnosed with the availability of better ultrasound imaging quality, the data on the best method to manage DDVT have been conflicting. The aim of the present review was to summarize the current and evidence-based recommendations for the diagnosis and management of DDVT and to provide a summary of the most recent societal guideline recommendations. A literature review of DDVT was performed. The PubMed databases were queried for articles on the epidemiology, risk factors, diagnosis, and management of DDVT. The prevalence of isolated DDVT has been reported in a broad range. The reported risk factors include older age, active malignancy, a low degree of mobility, acute infection, and atrial fibrillation. With more evidence, anticoagulation therapy was found to be associated with a reduced risk of recurrent venous thromboembolism (VTE) and/or thrombus propagation compared with conservative management. However, anticoagulation was associated with an increased risk of bleeding in a number of studies. The rate of VTE recurrence ranged from 7% to 23% during a follow-up period ranging from 3 months to 8 years. The significant risk factors for VTE recurrence included cancer, older age, an unprovoked event, and inpatient status. Few studies have addressed the diagnosis and management of DDVT. Further research is needed to standardize the best approach to diagnose and treat DDVT.
Identifiants
pubmed: 33578030
pii: S2213-333X(21)00084-6
doi: 10.1016/j.jvsv.2021.01.018
pii:
doi:
Substances chimiques
Anticoagulants
0
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1062-1070.e6Informations de copyright
Copyright © 2021 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.